Quick Answer
ANGIODYNAMICS INC reported Research And Development Expense of $26.22 million for the year ending 2025.
- ANGIODYNAMICS INC showed a decrease of -16.8% in Research And Development Expense from 2024 to 2025.
- This data is from ANGIODYNAMICS INC's annual report (Form 10-K), filed with the SEC on July 18, 2025.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), ANGIODYNAMICS INC's Research And Development Expense has grown by 36.0%.
- Historical annual values: Fiscal year 2025: $26.22 million | Fiscal year 2024: $31.51 million | Fiscal year 2023: $29.88 million | Fiscal year 2022: $30.74 million | Fiscal year 2021: $36.39 million | Fiscal year 2020: $29.68 million | Fiscal year 2019: $28.26 million | Fiscal year 2018: $24.34 million | Fiscal year 2017: $24.15 million | Fiscal year 2016: $25.05 million | Fiscal year 2015: $26.59 million | Fiscal year 2014: $28.12 million | Fiscal year 2013: $26.09 million | Fiscal year 2012: $20.51 million | Fiscal year 2011: $21.37 million | Fiscal year 2010: $19.28 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: